Alkermes (ALKS) News Today $29.25 +0.27 (+0.93%) Closing price 04:00 PM EasternExtended Trading$29.30 +0.05 (+0.17%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALKS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period MetLife Investment Management LLC Boosts Stock Position in Alkermes plc $ALKSAugust 27 at 7:30 AM | marketbeat.com75,069 Shares in Alkermes plc $ALKS Purchased by Campbell & CO Investment Adviser LLCAugust 27 at 7:13 AM | marketbeat.comAlkermes to Present Detailed Positive Results From Vibrance-1 Phase 2 Study Evaluating Alixorexton in Patients With Narcolepsy Type 1 at World Sleep 2025August 25 at 7:00 AM | prnewswire.comPrice T Rowe Associates Inc. MD Sells 468,202 Shares of Alkermes plc $ALKSAugust 25 at 5:51 AM | marketbeat.comWhat is Zacks Research's Forecast for Alkermes Q3 Earnings?August 24 at 7:32 AM | marketbeat.comWellington Management Group LLP Sells 3,915,604 Shares of Alkermes plc $ALKSAugust 24 at 5:15 AM | marketbeat.comRussell Investments Group Ltd. Purchases 147,906 Shares of Alkermes plc $ALKSAugust 24 at 3:51 AM | marketbeat.comZacks Research Predicts Alkermes' Q3 Earnings (NASDAQ:ALKS)August 24 at 2:17 AM | americanbankingnews.comZacks Research Predicts Alkermes' Q1 Earnings (NASDAQ:ALKS)August 23, 2025 | marketbeat.comAberdeen Group plc Has $5.18 Million Position in Alkermes plc $ALKSAugust 23, 2025 | marketbeat.comInvesco Ltd. Has $24.29 Million Stake in Alkermes plc $ALKSAugust 23, 2025 | marketbeat.com176,859 Shares in Alkermes plc $ALKS Bought by Algert Global LLCAugust 21, 2025 | marketbeat.comBrokerages Set Alkermes plc (NASDAQ:ALKS) PT at $41.08August 21, 2025 | americanbankingnews.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS), Staar Surgical (STAA) and Arvinas Holding Company (ARVN)August 19, 2025 | theglobeandmail.comAmerican Century Companies Inc. Buys 14,967 Shares of Alkermes plc (NASDAQ:ALKS)August 19, 2025 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Given Consensus Recommendation of "Moderate Buy" by BrokeragesAugust 19, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Takes $1.58 Million Position in Alkermes plc (NASDAQ:ALKS)August 18, 2025 | marketbeat.comSwiss National Bank Has $9.83 Million Stock Position in Alkermes plc (NASDAQ:ALKS)August 18, 2025 | marketbeat.comDeutsche Bank AG Cuts Stock Holdings in Alkermes plc (NASDAQ:ALKS)August 18, 2025 | marketbeat.comFox Run Management L.L.C. Sells 33,134 Shares of Alkermes plc (NASDAQ:ALKS)August 17, 2025 | marketbeat.comNeuberger Berman Group LLC Buys 187,667 Shares of Alkermes plc (NASDAQ:ALKS)August 17, 2025 | marketbeat.comJPMorgan Chase & Co. Has $172.86 Million Stake in Alkermes plc (NASDAQ:ALKS)August 16, 2025 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Shares Acquired by Citigroup Inc.August 16, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 21,558 Shares of Alkermes plc (NASDAQ:ALKS)August 16, 2025 | marketbeat.comNuveen LLC Buys New Position in Alkermes plc (NASDAQ:ALKS)August 15, 2025 | marketbeat.comVanguard Group Inc. Sells 283,511 Shares of Alkermes plc (NASDAQ:ALKS)August 15, 2025 | marketbeat.comPiper Sandler Keeps Their Buy Rating on Alkermes (ALKS)August 14, 2025 | theglobeandmail.comInformed Momentum Co LLC Buys New Stake in Alkermes plc (NASDAQ:ALKS)August 13, 2025 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Shares Purchased by Public Sector Pension Investment BoardAugust 13, 2025 | marketbeat.comPrimecap Management Co. CA Has $99.20 Million Stock Holdings in Alkermes plc (NASDAQ:ALKS)August 8, 2025 | marketbeat.com31,200 Shares in Alkermes plc (NASDAQ:ALKS) Bought by AXS Investments LLCAugust 8, 2025 | marketbeat.comJefferies Financial Group Inc. Makes New $410,000 Investment in Alkermes plc (NASDAQ:ALKS)August 7, 2025 | marketbeat.comFederated Hermes Inc. Sells 274,659 Shares of Alkermes plc (NASDAQ:ALKS)August 5, 2025 | marketbeat.comVestcor Inc Has $880,000 Holdings in Alkermes plc (NASDAQ:ALKS)August 4, 2025 | marketbeat.comHC Wainwright Brokers Boost Earnings Estimates for AlkermesAugust 4, 2025 | marketbeat.comEquities Analysts Set Expectations for Alkermes Q1 EarningsAugust 2, 2025 | marketbeat.comMackenzie Financial Corp Cuts Holdings in Alkermes plc (NASDAQ:ALKS)August 2, 2025 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Shares Sold by TD Asset Management IncAugust 2, 2025 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Stock Holdings Raised by XTX Topco LtdAugust 1, 2025 | marketbeat.comAlkermes Earnings Call: Strong Growth and Promising TrialsJuly 31, 2025 | theglobeandmail.comALKS- Positive Narcolepsy Drug Trial Puts this Biotech Name in FocusJuly 31, 2025 | finance.yahoo.comRoyal Bank Of Canada Forecasts Strong Price Appreciation for Alkermes (NASDAQ:ALKS) StockJuly 31, 2025 | marketbeat.comAlkermes shares climb 5% following Q2 earnings and revenue beatJuly 30, 2025 | msn.comAlkermes PLC (ALKS) Q2 2025 Earnings Report Preview: What To ExpectJuly 30, 2025 | finance.yahoo.comAlkermes: A More Than Solid QuarterJuly 30, 2025 | seekingalpha.comAlkermes (NASDAQ:ALKS) Shares Gap Up After Better-Than-Expected EarningsJuly 30, 2025 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Q2 2025 Earnings Call TranscriptJuly 30, 2025 | msn.comAlkermes (NASDAQ:ALKS) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPSJuly 30, 2025 | marketbeat.comAlkermes' (ALKS) "Buy" Rating Reaffirmed at Needham & Company LLCJuly 30, 2025 | marketbeat.comAlkermes (NASDAQ:ALKS) Issues FY 2025 Earnings GuidanceJuly 30, 2025 | marketbeat.com Get Alkermes News Delivered to You Automatically Sign up to receive the latest news and ratings for ALKS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ALKS Media Mentions By Week ALKS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALKS News Sentiment▼0.560.97▲Average Medical News Sentiment ALKS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALKS Articles This Week▼258▲ALKS Articles Average Week Get the Latest News and Ratings for ALKS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Alkermes and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Abeona Therapeutics News Medpace News Omnicell News AMN Healthcare Services News Incyte News United Therapeutics News Neurocrine Biosciences News BioMarin Pharmaceutical News Exelixis News Madrigal Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALKS) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alkermes plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alkermes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access